Literature DB >> 11421739

Synthetic derivatives of abietic acid with radical scavenging activity.

M A Esteves1, N Narender, M J Marcelo-Curto, B Gigante.   

Abstract

In this work, studies on the arylation of anilines derived from dehydroabietic acid, the main component of disproportionated rosin, are presented. The redox properties of the new diarylamines were investigated by cyclic voltammetry, and their free radical scavenging activity was tested by reduction of the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical. Three of the diarylamines with lower oxidation potential proved to be as active as isopropyldiphenylamine (IPPD) and superior to tert-butylhydroxytoluene (BHT), both commercially available synthetic antioxidants.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11421739     DOI: 10.1021/np000501y

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  4 in total

1.  Pharmacophore mapping of arylamino-substituted benzo[b]thiophenes as free radical scavengers.

Authors:  Indrani Mitra; Achintya Saha; Kunal Roy
Journal:  J Mol Model       Date:  2010-03-01       Impact factor: 1.810

2.  Synthesis and biological evaluation of 2-aryl-benzimidazole derivatives of dehydroabietic acid as novel tubulin polymerization inhibitors.

Authors:  Ting-Ting Miao; Xu-Bing Tao; Dong-Dong Li; Hao Chen; Xiao-Yan Jin; Yi Geng; Shi-Fa Wang; Wen Gu
Journal:  RSC Adv       Date:  2018-05-16       Impact factor: 4.036

3.  Fluorescence characteristics of some dehydroabietic acid-based arylamines.

Authors:  H D Burrows; N Chattopadhyay; M A Esteves; M Fernandes; B Gigante
Journal:  J Fluoresc       Date:  2007-08-01       Impact factor: 2.525

4.  Ferrostatins inhibit oxidative lipid damage and cell death in diverse disease models.

Authors:  Rachid Skouta; Scott J Dixon; Jianlin Wang; Denise E Dunn; Marina Orman; Kenichi Shimada; Paul A Rosenberg; Donald C Lo; Joel M Weinberg; Andreas Linkermann; Brent R Stockwell
Journal:  J Am Chem Soc       Date:  2014-03-14       Impact factor: 15.419

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.